El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2007
NCT05131295
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

El Instituto Nacional de Neurologia Manuel Velasco Suarez | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 2)

Ischemia (Phase 3)

Motor Neuron Disease (Phase 2)

Parkinson Disease (Phase 2)

Sclerosis (Phase 2)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 7